Biomarin Pharmaceutical Inc (BMRN) Hedge Fund & Institutional Holdings (Q2 2026)

BMRN ranks #1021 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

BMRN is a top-conviction position for Jones Hill Capital LP — at 17.4% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in BMRN belongs to BlackRock, Inc., but the position matters far more to Jones Hill Capital LP, who has 17.4% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

California State Teachers Retirement System has added to its BMRN position for two straight quarters, increasing it by $193.5M to reach $203.8M today.

Squarepoint Ops LLC has trimmed its BMRN position for two straight quarters, cutting it by $103.0M while still holding $6.1M.

BMRN is up 3.3% today, and institutions have been net buyers of $1.6B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

BMRN posted net income of $73.0M over the trailing twelve months, and currently trades at a P/E of 181.2.

• Profitable — net income of $73.0M over the trailing twelve months
• Revenue grew 11.2% year over year
• Net income declined year over year, from $657.2M to $73.0M
• Generated $828.0M in positive operating cash flow
• Current ratio of 5.21x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.25x equity — within a conventional range